Cargando…

Cardiovascular Risk Factors in Bulgarian Patients with Polycystic Ovary Syndrome and/or Obesity

Polycystic ovarian syndrome (PCOS) is one of the most common endocrine disturbances in women of reproductive age. Besides its well-known effects on reproductive health, it is also linked to increased cardiovascular risk in later life. The aim of this study is to investigate some classical cardiovasc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gateva, Antoaneta, Kamenov, Zdravko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3259489/ https://www.ncbi.nlm.nih.gov/pubmed/22262974 http://dx.doi.org/10.1155/2012/306347

Ejemplares similares

Comparing the Efficacy of Myo-Inositol Plus α-Lactalbumin vs. Myo-Inositol Alone on Reproductive and Metabolic Disturbances of Polycystic Ovary Syndrome
por: Kamenov, Zdravko, et al.
Publicado: (2023)

Elevated levels of interleukin-18 are associated with several indices of general and visceral adiposity and insulin resistance in women with polycystic ovary syndrome
por: Kabakchieva, Plamena, et al.
Publicado: (2022)

Inositols in PCOS
por: Kamenov, Zdravko, et al.
Publicado: (2020)

Effectiveness and Tolerability of Second-Line Therapy with Vildagliptin Versus Other Oral Agents in Type 2 Diabetes (EDGE): Post Hoc Sub-Analysis of Bulgarian Data
por: Kamenov, Zdravko
Publicado: (2014)

Phenotype and Metabolic Disorders in Polycystic Ovary Syndrome
por: Głuszak, Olgierd, et al.
Publicado: (2012)

Extended High Frequency Audiometry in Polycystic Ovary Syndrome
por: Kucur, Cuneyt, et al.
Publicado: (2013)

Risks for Gestational Diabetes Mellitus and Pregnancy-Induced Hypertension Are Increased in Polycystic Ovary Syndrome
por: Wang, Yunhui, et al.
Publicado: (2013)

The Effects of Oral Isotretinoin in Women with Acne and Polycystic Ovary Syndrome
por: Acmaz, G., et al.
Publicado: (2019)

Retinal Nerve Fiber Layer Thickness in Women with Polycystic Ovary Syndrome
por: Demir, Mehmet, et al.
Publicado: (2013)

Biomediators in Polycystic Ovary Syndrome and Cardiovascular Risk
por: Pandurevic, Srdan, et al.
Publicado: (2021)

Diamel Therapy in Polycystic Ovary Syndrome Reduces Hyperinsulinaemia, Insulin Resistance, and Hyperandrogenaemia
por: Hernández-Yero, Arturo, et al.
Publicado: (2012)

Clinical and biochemical signs of polycystic ovary syndrome in young women born preterm
por: Paalanne, Marika, et al.
Publicado: (2021)

Increased risk of obstructive sleep apnoea in women with polycystic ovary syndrome: a population-based cohort study
por: Kumarendran, Balachandran, et al.
Publicado: (2019)

Levels of Neopterin and other Inflammatory Markers in Obese and Non-Obese Patients with Polycystic Ovary Syndrome
por: Agacayak, Elif, et al.
Publicado: (2015)

Women with Polycystic Ovary Syndrome and Risk of Cardiovascular Disease
por: Blagojevic, Iva Perovic, et al.
Publicado: (2017)

Cardiovascular disease risk in offspring of polycystic ovary syndrome
por: Shawky, Noha M.
Publicado: (2022)

Prevalence and Clinical Predictors of Insulin Resistance in Reproductive-Aged Thai Women with Polycystic Ovary Syndrome
por: Wongwananuruk, Thanyarat, et al.
Publicado: (2012)

Increased COVID-19 infections in women with polycystic ovary syndrome: a population-based study
por: Subramanian, Anuradhaa, et al.
Publicado: (2021)

Prevalence of Positive Diabetes-Associated Autoantibodies among Type 2 Diabetes and Related Metabolic and Inflammatory Differences in a Sample of the Bulgarian Population
por: Zaharieva, Emanuela Tsvetkova, et al.
Publicado: (2017)

Dosage Optimization for Letrozole Treatment in Clomiphene-Resistant Patients with Polycystic Ovary Syndrome: A Prospective Interventional Study
por: Rahmani, Elham, et al.
Publicado: (2012)

Circulating ANGPTL8 Is Associated with the Presence of Metabolic Syndrome and Insulin Resistance in Polycystic Ovary Syndrome Young Women
por: Pu, Danlan, et al.
Publicado: (2019)

Short-term combined treatment with liraglutide and metformin leads to significant weight loss in obese women with polycystic ovary syndrome and previous poor response to metformin
por: Jensterle Sever, Mojca, et al.
Publicado: (2014)

Association between Hypoadiponectinemia and Low Serum Concentrations of Calcium and Vitamin D in Women with Polycystic Ovary Syndrome
por: Mazloomi, Sahar, et al.
Publicado: (2012)

Pericardial Fat Relates to Disturbances of Glucose Metabolism in Women with the Polycystic Ovary Syndrome, but Not in Healthy Control Subjects
por: Leutner, Michael, et al.
Publicado: (2018)

Association between Insulin Resistance and Cardiovascular Risk Factors in Polycystic Ovary Syndrome Patients
por: Wanderley, Miriam da Silva, et al.
Publicado: (2018)

Stress Hyperglycemia, Diabetes Mellitus and COVID-19 Infection: Risk Factors, Clinical Outcomes and Post-Discharge Implications
por: Gerganova, Antonina, et al.
Publicado: (2022)

Racial and Ethnic Differences in Metabolic Disease in Adolescents With Obesity and Polycystic Ovary Syndrome
por: Andrisse, Stanley, et al.
Publicado: (2021)

Pharmacological Treatment of Obesity in Patients with Polycystic Ovary Syndrome
por: Kahal, Hassan, et al.
Publicado: (2011)

Pharmacological Management of Obesity in Patients with Polycystic Ovary Syndrome
por: Kourtidou, Christodoula, et al.
Publicado: (2023)

Why are women with polycystic ovary syndrome obese?
por: Barber, T M
Publicado: (2022)

Liver Injury Indicating Fatty Liver but Not Serologic NASH Marker Improves under Metformin Treatment in Polycystic Ovary Syndrome
por: Tan, Susanne, et al.
Publicado: (2015)

The Prevalence of Cardiovascular Disease Risk Factors and Obesity in Firefighters
por: Smith, Denise L., et al.
Publicado: (2012)

Cigarette Smoking and Cardiovascular Risk in Young Women with Polycystic Ovary Syndrome
por: Morotti, Elena, et al.
Publicado: (2014)

The Effect of Exenatide on Cardiovascular Risk Markers in Women With Polycystic Ovary Syndrome
por: Dawson, Alison J., et al.
Publicado: (2019)

The cardiovascular risk profile of middle‐aged women with polycystic ovary syndrome
por: Meun, Cindy, et al.
Publicado: (2019)

Androgen-Induced Cardiovascular Risk in Polycystic Ovary Syndrome: The Role of T Lymphocytes
por: Moulana, Mohadetheh
Publicado: (2023)

11-Oxyandrogens in Adolescents With Polycystic Ovary Syndrome
por: Taylor, Anya E, et al.
Publicado: (2022)

Polycystic ovary syndrome and risk factors for gestational diabetes
por: Mustaniemi, Sanna, et al.
Publicado: (2018)

Coronary artery disease risk in young women with polycystic ovary syndrome
por: Ding, Dah-Ching, et al.
Publicado: (2018)

Obesity and Outcome of Assisted Reproduction in Patients With Polycystic Ovary Syndrome
por: Tziomalos, Konstantinos, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_vpdd3tpqivjvoe7qbhhq83k68v